Navigation Links
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
Date:5/9/2013

hypomagnesemia, nausea, vomiting and constipation.

To see the U.S. Vectibix Prescribing Information, visit www.vectibix.com.

Amgen Forward-Looking Statements
This news release contains forward-looking statements that are based on Amgen's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described.  All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results.  Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and Form 8-K.  Please refer to Amgen's most recent Form 10-K and any subsequent Forms 10-Q and 8-K for additional information on the uncertainties and risk factors related to Amgen's business.  Unless otherwise noted, Amgen is providing this information as of May 9, 2013, and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those Amgen projects.  Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or dev
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  Today, Levi ... new extension to its PageCenterX ® content ... is designed to provide downtime reporting capabilities to ... LRS is releasing the product for general availability, ... EMR applications experience outages for a variety of ...
(Date:7/31/2014)... and WASHINGTON , July 31, ... CVS/pharmacy is the first pharmacy in the nation ... URAC, the leading health care accreditation organization that ... All CVS/pharmacy and Longs Drug Store locations nationwide ... has over 30 accreditation programs. Its Community Pharmacy ...
(Date:7/31/2014)... 31, 2014 HeartWare International, Inc . ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... of $70.1 million for the second quarter ended June ... in revenue for the same period of 2013. ... Ventricular Assist Systems were sold globally compared to 523 ...
Breaking Medicine Technology:LRS Announces Downtime Reporting Solution for Healthcare 2CVS/pharmacy Earns First-Ever Community Pharmacy Accreditation from URAC 2CVS/pharmacy Earns First-Ever Community Pharmacy Accreditation from URAC 3HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 2HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 3HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 4HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 5HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 6HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 7HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 8HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 9HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 10HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 11HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 12
... 2011 West Pharmaceutical Services, Inc. (NYSE: WST ... of 2011.  Summary comparative results were as follows:($ millions, except ... , $ 274.7Gross Profit , 88.0 , 82.2Reported Operating Profit ... , 29.5Reported Diluted EPS , $ 0.56 , $ 0.57Adjusted ...
... (Nasdaq and MTA: CTIC) (the "Company") today announced that it ... customary closing conditions, approximately $16.0 million of shares of ... shares of its common stock in a registered offering ... Preferred Stock is convertible at the option of the ...
Cached Medicine Technology:West Announces First Quarter 2011 Results 2West Announces First Quarter 2011 Results 3West Announces First Quarter 2011 Results 4West Announces First Quarter 2011 Results 5West Announces First Quarter 2011 Results 6West Announces First Quarter 2011 Results 7West Announces First Quarter 2011 Results 8West Announces First Quarter 2011 Results 9West Announces First Quarter 2011 Results 10West Announces First Quarter 2011 Results 11West Announces First Quarter 2011 Results 12West Announces First Quarter 2011 Results 13West Announces First Quarter 2011 Results 14Cell Therapeutics, Inc. Announces Institutional Investors Purchase Approximately $16.0 Million of Preferred Stock and Warrants 2Cell Therapeutics, Inc. Announces Institutional Investors Purchase Approximately $16.0 Million of Preferred Stock and Warrants 3
(Date:7/31/2014)... Coral, FL (PRWEB) July 31, 2014 ... opportunity to take charge of their financial future. ... for women, has opened registration for 6 upcoming Los ... by women, for women, and with input from Kim ... Woman and It’s Rising Time) who is passionate about ...
(Date:7/31/2014)... use has been rising steadily in the U.S in ... Use and Health, the number of individuals reporting past ... 2012 (669,000). Emerging evidence suggests the increase may be ... oral and/or intranasal PO use to heroin use, with ... ultimately, heroin injection. This drug-use trajectory appears to ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Clifton Dental ... the application of topical fluoride treatments to their adult ... and help with tooth sensitivity in patients that exhibit ... an infection that is commonly known as “tooth decay” ... tissues of the teeth. , Fluoride therapy ...
(Date:7/31/2014)... HealthDay Reporter THURSDAY, July 31, 2014 ... experiences, are a source of drinking problems among U.S. National ... Setbacks such as job loss, divorce and financial problems -- ... as 13 percent of vets turn to drink, researchers found. ... effect on mental health in the short term, but what ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The ... in Lake Como, NJ, is proud to announce ... services! , Advanced PMR proudly offers many services, ... They also offer medical supplies. Some of their ... pediatric therapy, and geriatric therapy among a vast ...
Breaking Medicine News(10 mins):Health News:The Independent Woman to Offer Financial Workshops in the Los Angeles Area - Developed by Women for Women 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 3Health News:NJ Top Dentists Approved, Clifton Dental Associates Now Actively Recommending the Application of Topical Fluoride Treatments to Adults 2Health News:Civilian Life, Not Combat, May Drive Many Veterans to Drink 2Health News:Civilian Life, Not Combat, May Drive Many Veterans to Drink 3Health News:NJ Top Docs' Approved, Advanced Physical Medicine and Rehabilitation Now Offering Chiropractic & Podiatric Services 2
... love Scent To Sleep products so much, we bought ... (ICP) announced today that ICP has acquired Scent To ... and distributes a revolutionary All Natural Non-Drowsy Sleep Mist ... love Scent To Sleep products so much, we bought ...
... , Q1 Revenue Increases ... Foreign Exchange Rates Lead to Improved Gross Margin Percentage. ... Revenue Faster Than Cost of Sales and Operating Expenses. , ... $1.20 per share. , , , Eli ...
... Social Security representative , ... Belleville, IL (Vocus) April ... they hire a representative to help them apply, according to ... Social Security Disability Insurance (SSDI) process each year., , ...
... DENVER Treatment with biphosphonates could prevent radiation-induced leukemia, ... Cancer Research 100th Annual Meeting 2009. , Alexandra ... Radiobiology Research Institute, said her research is designed to ... likely to be exposed to risky levels of radiation ...
... at specific tumor traits , , SUNDAY, April 19 (HealthDay ... who had been faring poorly on less finely tuned ... targeted to their tumors, specific characteristics. , The ... American Association for Cancer Research annual meeting, in Denver, ...
... liver cells transplanted by infusion or injection will find ... tissue, start proliferating, and take over the liver,s work ... worn-out cells from the blood. Hepatocyte transplantation has been ... that use of cells could overcome the shortage of ...
Cached Medicine News:Health News:Scent To Sleep All Natural Non-Drowsy Sleep Mist Acquired by Innovative Custom Products, Inc. (ICP) 2Health News:Lilly Reports Strong First-Quarter 2009 Results 2Health News:Lilly Reports Strong First-Quarter 2009 Results 3Health News:Lilly Reports Strong First-Quarter 2009 Results 4Health News:Lilly Reports Strong First-Quarter 2009 Results 5Health News:Lilly Reports Strong First-Quarter 2009 Results 6Health News:Lilly Reports Strong First-Quarter 2009 Results 7Health News:Lilly Reports Strong First-Quarter 2009 Results 8Health News:Lilly Reports Strong First-Quarter 2009 Results 9Health News:Lilly Reports Strong First-Quarter 2009 Results 10Health News:Lilly Reports Strong First-Quarter 2009 Results 11Health News:Lilly Reports Strong First-Quarter 2009 Results 12Health News:Lilly Reports Strong First-Quarter 2009 Results 13Health News:Lilly Reports Strong First-Quarter 2009 Results 14Health News:Lilly Reports Strong First-Quarter 2009 Results 15Health News:Lilly Reports Strong First-Quarter 2009 Results 16Health News:Lilly Reports Strong First-Quarter 2009 Results 17Health News:More Social Security Disability Applicants Are Seeking Representation 2Health News:More Social Security Disability Applicants Are Seeking Representation 3Health News:More Social Security Disability Applicants Are Seeking Representation 4Health News:More Social Security Disability Applicants Are Seeking Representation 5Health News:More Social Security Disability Applicants Are Seeking Representation 6Health News:Targeted Treatments Show Mettle Against Advanced Cancers 2Health News:Targeted Treatments Show Mettle Against Advanced Cancers 3Health News:Transplanted liver cells function in older animals but do not proliferate as much as in younger ones 2
... Offering a unique, empowering alternative to ... industry for years, MMD's PalmScan AP2000 is ... and Pachymeter combination unit on the market ... ounces and is able to perform multiple ...
... is an accurate, reliable, portable, and ... It works off of a dual-rechargeable ... the device a breeze. The large, ... operating and viewing results simple. Built ...
The Cordis ANGIOGUARD Capture Guidewire is the first embolic protection device shown in clinical testing to achieve a relative stroke reduction of 70% during carotid stenting procedures....
... TOX/See™ is a 1-step, hand-held, point-of-care device for ... in human urine. The TOX/See device can ... abused drugs in 3 to 8 minutes and ... TOX/See cassette is individually packaged to maximize convenience ...
Medicine Products: